Oligonucleotides, agents containing these oligonucleotides,...

Details Oligonucleotides, agents containing these oligonucleotides,... Oligonucleotides, agents containing these oligonucleotides,...

2001-09-28

2009-10-27

Chong, Kimberly (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S024310, C435S006120, C435S325000, C435S375000, C514S04400A

Reexamination Certificate

active

07608705

ABSTRACT:
The invention relates to particular oligonucleotides, pharmaceutical agents that contain these oligonucleotides, and to the therapeutic use thereof. The oligonucleotides are, in particular, capable of inhibiting the proliferation of pancreatic tumors. These oligonucleotides thus have a therapeutic potential for the treatment of pancreatic tumors. This can involve, in the broadest sense, an antisense therapy.

REFERENCES:
patent: 5245022 (1993-09-01), Weis et al.
patent: 5552390 (1996-09-01), Scholar et al.
patent: 6365577 (2002-04-01), Iversen
patent: 6395492 (2002-05-01), Manoharan et al.
patent: 6972171 (2005-12-01), Schlingensiepen et al.
patent: 2004/0241651 (2004-12-01), Olek et al.
patent: 2005/0019761 (2005-01-01), Bayer et al.
patent: WO-02/26754 (2002-04-01), None
Mier e tal. Preparation and Evaluation of Tumor-Targeting Peptide-Oligonucleotide Conjugates. Bioconjugate Chem 2000, Vo. 11:855-860.
Neuzil et al. Induction of cancer cell apoptosis by alpha-tcopherl succinate: molecular pathways and structural requirements. FASEB 2001, vol. 15: 403-415.
Mata et al. Evidence of Enhanced Iron excretion during systemic phosphorothiate oligodeoxynucleotide treatment. Journal of Toxicology 2000, vol. 38, No. 4.: 383-387.
Sharp et al. Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells. Leuk Lymphoma, 2001.
Bayer, Ernst et al., “Synthesis of 3'-PEG-Modified Oligonucleotides on PS-PEG Tentacle Polymers,”Z. Naturforsch, vol. 50b:671-676 (1995).
Fearon, Karen L. et al., “Investigation of the ‘n-1’ impurity in phosphorothioate oligodeoxynucleotides synthesized by the solid-phase β-cyanoethyl phosphoramidite method using stepwise sulfurization,”Nucleic Acids Research, vol. 23(14):2754-2761 (1995).
Fiedler, Alexander et al., “Growth inhibition of pancreatic tumor cells by modified antisense oligodeoxynucleotides,”Langenbeck's Arch. Surg., vol. 383:269-275 (1998).
Hahn, Stephen A. et al., “Recent Discoveries in Cancer Genetics of Exocrine Pancreatic Neoplasia,”Digestion, vol. 59:493-501 (1998).
Hirota, Yasuhide et al., “p53 Antisense Oligonucleotide Inhibits Growth of Human Colon Tumor and Normal Cell Lines,”Jpn. J. Cancer Res., vol. 87:735-742 (1996).
Lebedeva, Irina et al., “Cellular delivery of antisense oligonucleotides,”European Journal of Pharmaceutics and Biopharmaceutics, vol. 50:101-119 (2000).
Maier, Martin et al., “Enzymatic Degradation of Various Antisense Oligonucleotides: Monitoring and Fragment Indentification by MECC adn ES-MS,”Biomedical Peptides, Proteins&Nucleic Acids, vol. 1:235-242 (1995).
Manoharan, Muthiah et al., “Oligonucleotide Conjugates: Alteration of the PHarmacokinetic Properties of Antisense Agents,”Nucleosides&Nucleotides, vol. 14(3-5):969-973 (1995).

Affiliated with

Also associated with

Rating

Oligonucleotides, agents containing these oligonucleotides,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligonucleotides, agents containing these oligonucleotides,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides, agents containing these oligonucleotides,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4089731